Podcast
Questions and Answers
What is a key component of the watchful waiting approach?
What is a key component of the watchful waiting approach?
- Regular reassessment at intervals (correct)
- Daily medication administration
- Immediate surgical intervention
- Permanent lifestyle changes
How often are patients reassessed under a watchful waiting strategy?
How often are patients reassessed under a watchful waiting strategy?
- Every month
- Once a year
- Every 6–12 months (correct)
- Every 3 months
What type of education is emphasized for patients in the watchful waiting approach?
What type of education is emphasized for patients in the watchful waiting approach?
- Surgical options available
- Emergency procedures
- Pharmaceutical treatments
- Behavior modification techniques (correct)
What is NOT part of the watchful waiting approach?
What is NOT part of the watchful waiting approach?
Which statement best describes the watchful waiting strategy?
Which statement best describes the watchful waiting strategy?
What is the recommended prostate gland size for symptomatic patients to consider treatment?
What is the recommended prostate gland size for symptomatic patients to consider treatment?
At what PSA level should treatment considerations begin for symptomatic patients?
At what PSA level should treatment considerations begin for symptomatic patients?
Which treatment may be considered for patients with both erectile dysfunction and BPH?
Which treatment may be considered for patients with both erectile dysfunction and BPH?
What is the primary condition that phosphodiesterase inhibitors are used to address in this context?
What is the primary condition that phosphodiesterase inhibitors are used to address in this context?
Which option is NOT a consideration when treating symptomatic patients with prostate enlargement?
Which option is NOT a consideration when treating symptomatic patients with prostate enlargement?
Which of the following agents is NOT indicated for treating storage symptoms?
Which of the following agents is NOT indicated for treating storage symptoms?
Which of these agents is primarily used for treating irritative voiding symptoms?
Which of these agents is primarily used for treating irritative voiding symptoms?
Which combination includes only agents that treat storage symptoms?
Which combination includes only agents that treat storage symptoms?
Which of the following agents is a selective muscarinic receptor antagonist used for storage symptoms?
Which of the following agents is a selective muscarinic receptor antagonist used for storage symptoms?
What is the primary reason Tadalafil is preferred over other phosphodiesterase inhibitors?
What is the primary reason Tadalafil is preferred over other phosphodiesterase inhibitors?
Which agent is least likely to be used for treating irritative voiding symptoms?
Which agent is least likely to be used for treating irritative voiding symptoms?
How does Tadalafil affect voiding symptoms?
How does Tadalafil affect voiding symptoms?
Which effect does Tadalafil NOT have according to the information provided?
Which effect does Tadalafil NOT have according to the information provided?
What outcome is associated with Tadalafil's use in patients?
What outcome is associated with Tadalafil's use in patients?
In what context is Tadalafil particularly advantageous?
In what context is Tadalafil particularly advantageous?
What is the primary action of phosphodiesterase inhibitors on smooth muscle tone?
What is the primary action of phosphodiesterase inhibitors on smooth muscle tone?
What intracellular molecule do phosphodiesterase inhibitors increase?
What intracellular molecule do phosphodiesterase inhibitors increase?
Which of the following areas is affected by the action of phosphodiesterase inhibitors?
Which of the following areas is affected by the action of phosphodiesterase inhibitors?
How do phosphodiesterase inhibitors affect the prostate?
How do phosphodiesterase inhibitors affect the prostate?
What effect do phosphodiesterase inhibitors have on cyclic guanosine monophosphate levels?
What effect do phosphodiesterase inhibitors have on cyclic guanosine monophosphate levels?
Study Notes
Watchful Waiting
- Patients with a prostate gland more than 40g and PSA of 1.4 ng/mL or more are reassessed every 6-12 months
- Patients are educated about behavior modification
- Consider using a phosphodiesterase inhibitor (PI) alone or in combination with an α-adrenergic antagonist if erectile dysfunction and BPH are present
Phosphodiesterase Inhibitors
- Increase intracellular cyclic guanosine monophosphate
- Relax smooth muscle of the detrusor, prostate, and urethra
- Tadalafil is preferred due to its longer plasma half-life
- Improves voiding symptoms but does not increase urinary flow rate or reduce PVR urine volume
Other Medications for Storage Symptoms
- Darifenacin, fesoterodine, oxybutynin, propiverine, solifenacin, tolterodine and trospium are available to treat storage symptoms (irritative voiding symptoms)
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz covers the management of prostate health, focusing on watchful waiting strategies, the use of phosphodiesterase inhibitors, and other medications for storage symptoms. Learn about patient assessments, behavioral modifications, and the pharmacological treatments available for benign prostatic hyperplasia (BPH) and related symptoms.
